United States · Investor

Psilos Group

Last cheque observed Sep 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $42M, Mar 2015Private equity

Series BSeries CSeries AConsumer GoodsDeliveryVenture Capital & Private Equity

Cheques on record
0%of best year0cheques in 12 months, 20 on record
Since the last cheque3318days00hrs00min00sec
Median round$25MRounds led0 of 20Sole investor3 roundsExits5 from the portfolioMostly inUnited States, 95%
Pitch Psilos Group

Psilos Group highlights

  1. 01

    20 rounds on record

  2. 02

    Mostly Series B and Series C: 67% of its rounds

  3. 03

    Sole investor in 3 rounds, median $10M

  4. 04

    5 exits from the portfolio

What they do

Filed 1 private fund offering with the SEC, the most recent in 2015-03From their own website
Type
Private equity (from a list, unverified)
Cheque size
Not stated
Sectors
Consumer GoodsDeliveryVenture Capital & Private Equity
Based in
New York, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first20 appearances

  1. 2017

    1 round

  2. Sept
    PatientSafeUS · FinSMEs$25MWith 3 others
  3. 2014

    1 round

  4. Oct
    Gamma MedicaSeries B · US$12MWith 1 other
  5. 2013

    4 rounds

  6. Sept
    PatientSafe SolutionsSeries C · US · finsmes.com$7.0MWith 3 others
  7. Jul
    Gamma MedicaSeries A · US · finsmes.com$16MSole investor
  8. Jan
    SeeChange HealthSeries C · US · finsmes.com$15MWith 1 other
  9. Jan
    PatientSafe SolutionsSeries C · US · finsmes.com$20MWith 2 others
  10. 2010

    1 round

  11. Mar
    PatientSafe SolutionsSeries B · US · onbiovc.com$30MWith 6 others
  12. 2009

    1 round

  13. Oct
    Gamma Medica-IdeasSeries A · US · onbiovc.com$14MWith 1 other
  14. 2008

    2 rounds

  15. May
    OmniGuideSeries E · US · venturebeat.com$25MWith 5 others
  16. Jan
    Mauna KeaSeries B · FR$30MWith 2 others
  17. 2007

    4 rounds

  18. Oct
    AngioScoreSeries E · US · angioscore.com$30MWith 5 others
  19. Aug
    Extend HealthSeries B · US · extendhealth.com$15MWith 1 other
  20. Apr
    Click4CareSeries A · US$10MSole investor
  21. Mar
    IntelliDOTSeries D · US$10MSole investor
  22. 2006

    2 rounds

  23. Nov
    Health Hero Network(Bosch Healthcare)Series B · US · deals.venturebeat.com$16MWith 5 others
  24. Oct
    VeraLightSeries B · US$18MWith 5 others
  25. 2004

    2 rounds

  26. Oct
    Acuity PharmaceuticalsSeries B · US$15MWith 5 others
  27. Jan
    deNovisSeries C · US$22MWith 4 others
  28. 2003

    1 round

  29. Jul
    Cohesive TechnologiesSeries B · US$9.5MWith 2 others
  30. 2001

    1 round

  31. Mar
    MRxonlineVenture · USUndisclosedWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

JMJeffrey M. KraussManaging Member of Psilos Group Investors IV, LLC (the ""General Partner"") the general partneriFiling they signed
JRJoseph R. RileyManaging Member of Psilos Group Investors IV, LLC (the ""General Partner"") the general partneriFiling they signed

We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed5 in all

AngioScoreBought by Spectranetics$230MMay 2014
Extend HealthBought by Towers Watson$435MMay 2012
Acuity PharmaceuticalsBought by OPKO HealthUndisclosedJun 2011
Health Hero Network(Bosch Healthcare)Bought by Robert Bosch GmBHUndisclosedDec 2008
Cohesive TechnologiesBought by Thermo Fisher ScientificUndisclosedJan 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Psilos Group. A count of rooms they were both in, not a relationship either has claimed.

Camden PartnersPrivate equity3rounds together3i GroupPrivate equity2rounds togetherCalifornia Technology VenturesVC firm2rounds togetherIntegral Capital PartnersGrowth equity2rounds togetherMerck Global Health Innovation FundCorporate VC2rounds togetherPelion Venture PartnersVC firm2rounds togetherTPGPrivate equity2rounds together

Quick answers about Psilos Group

What does Psilos Group invest in?

Psilos Group invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Consumer Goods, Delivery and Venture Capital & Private Equity.

How active is Psilos Group?

20 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2017.

What has Psilos Group invested in recently?

Its most recent investments on record: PatientSafe (Undisclosed round, Sept 2017).

How big are Psilos Group's cheques?

The median round it joins is $25M.

Does Psilos Group lead rounds?

Rarely, if at all: none of its 20 investments on record names it as the lead.

Where does Psilos Group invest?

Most of the companies it backs are in the United States (95%) and France (5%).

Is Psilos Group investing now?

No investments in the last 12 months; the latest was in Sept 2017.

Who does Psilos Group invest alongside?

Most often Camden Partners (3 rounds together), 3i Group (2 rounds together) and California Technology Ventures (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it